Recently awarded grants:
- Dr. Paolo Casali, chair of the Department of Microbiology, Immunology & Molecular Genetics (MIMG), was awarded a Training Grant (1 T32 AI138944-01) from the National Institutes of Health for the Graduate Research in Immunology Program (GRIP). Exceptional MIM discipline graduate students are selected for financial support of their research activities via this mechanism. It is noteworthy that selection for a position on the Training Grant is a great honor and provides an important addition to a student’s Curriculum vitae. Click here for more information.
Research grants awarded this past year:
- Dr. David Kadosh was recently awarded NIH R21 grant “Regulation of Protein Synthesis During the C. albicans-Macrophage Interaction”
- Dr. Paolo Casali was recently awarded a 5-year NIH R01 grant “Intrinsic B cell epigenetic regulation of antibody and autoantibody responses by Sirt1” from NIAID for $2,384,804 total award costs
- Dr. Guangming Zhong was recently awarded NIH R21 grant “Gut Microbiome and Chlamydia pathogenicity in the upper genital tract”
- Dr. Nu Zhang was recently awarded an American Cancer Society – Research Scholar Grant “Stroma and T cell interaction controls Tcf1 + CD8 T cells in tumor immunity”
- Dr. Thirumalai Kannan was recently awarded NIH R01 grant “Unique ADP-ribosylating and vacuolating properties of Mycoplasma pneumoniae CARDS toxin trigger airway inflammation and disease progression.”
- Dr. Alexei Tumanov was recently awarded a Morrison Trust grant “Crosstalk between nervous and immune system in in intestinal inflammation”
- Dr. Peter Dube was recently awarded a Basic and Clinical Science Pilot Program grant “Evaluation of preclinical models for neo-antigen based cancer vaccines”
- Dr. Ann Griffith’s graduate student, Sergio Cepeda was recently awarded an HHMI Gilliam Graduate Fellowship grant from the Howard Hughes Medical Institute.
- Dr. Guangming Zhong was recently awarded NIH R01 grant “In vitro passages to accumulate mutations in non-essential genes for identifying in vivo virulence factors”